Skip to content
Open access · CC-BY via OpenAlex

Clinical-grade human umbilical cord-derived mesenchymal stem cells improved skeletal muscle dysfunction in age-associated sarcopenia mice

Chao Wang, Bichun Zhao, Jinglei Zhai, Ailin Wang, Ning Cao, Tuling Liao, Ruyu Su, Lijuan He, Yanhua Li, Xuetao Pei, Yi Jia, Wen Yue

Cell Death and Disease · 2023 · ▲ 34 citations

Abstract

With the expansion of the aging population, age-associated sarcopenia (AAS) has become a severe clinical disease of the elderly and a key challenge for healthy aging. Regrettably, no approved therapies currently exist for treating AAS. In this study, clinical-grade human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) were administrated to two classic mouse models (SAMP8 mice and D-galactose-induced aging mice), and their effects on skeletal muscle mass and function were investigated by behavioral tests, immunostaining, and western blotting. Core data results showed that hUC-MSCs significantly restored skeletal muscle strength and performance in both mouse models via mechanisms including raising the expression of crucial extracellular matrix proteins, activating satellite cells, enhancing autophagy(definition), and impeding cellular aging. For the first time, the study comprehensively evaluates and demonstrates the preclinical efficacy of clinical-grade hUC-MSCs for AAS in two mouse models, which not only provides a novel model for AAS, but also highlights a promising strategy to improve and treat AAS and other age-associated muscle diseases. This study comprehensively evaluates the preclinical efficacy of clinical-grade hUC-MSCs in treating age-associated sarcopenia (AAS), and demonstrates that hUC-MSCs restore skeletal muscle strength and performance in two AAS mouse models via raising the expression of extracellular matrix proteins, activating satellite cells, enhancing autophagy, and impeding cellular aging, which highlights a promising strategy for AAS and other age-associated muscle diseases.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1038/s41419-023-05843-8
Canonical
link ↗
Fetched
2026-10-17 MST

Cite this

APA
Wang, C., Zhao, B., Zhai, J., Wang, A., Cao, N., Liao, T., Su, R., He, L., Li, Y., Pei, X., Jia, Y., &amp; Yue, W. (2023). Clinical-grade human umbilical cord-derived mesenchymal stem cells improved skeletal muscle dysfunction in age-associated sarcopenia mice. <em>Cell Death and Disease</em>. https://doi.org/10.1038/s41419-023-05843-8
Vancouver
Wang C, Zhao B, Zhai J, Wang A, Cao N, Liao T, et al. Clinical-grade human umbilical cord-derived mesenchymal stem cells improved skeletal muscle dysfunction in age-associated sarcopenia mice. Cell Death and Disease. 2023. doi:10.1038/s41419-023-05843-8.
BibTeX
@article{chao2023Clinic, title = {Clinical-grade human umbilical cord-derived mesenchymal stem cells improved skeletal muscle dysfunction in age-associated sarcopenia mice}, author = {Chao Wang and Bichun Zhao and Jinglei Zhai and Ailin Wang and Ning Cao and Tuling Liao and Ruyu Su and Lijuan He and Yanhua Li and Xuetao Pei and Yi Jia and Wen Yue}, journal = {Cell Death and Disease}, year = {2023}, doi = {10.1038/s41419-023-05843-8}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings